{"id":11834,"date":"2026-01-28T17:10:51","date_gmt":"2026-01-28T17:10:51","guid":{"rendered":"https:\/\/www.lupuscanada.org\/vaccination-contre-le-zona-dans-le-lupus-etude-de-recherche-catalyst-grant\/"},"modified":"2026-01-28T17:47:53","modified_gmt":"2026-01-28T17:47:53","slug":"vaccination-contre-le-zona-dans-le-lupus-etude-de-recherche-catalyst-grant","status":"publish","type":"post","link":"https:\/\/www.lupuscanada.org\/fr\/vaccination-contre-le-zona-dans-le-lupus-etude-de-recherche-catalyst-grant\/","title":{"rendered":"Vaccination contre le zona dans le lupus : \u00e9tude de recherche Catalyst Grant"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00a0\u00bb1&Prime; _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb-29px||||false|false\u00a0\u00bb da_disable_devices=\u00a0\u00bboff|off|off\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb da_is_popup=\u00a0\u00bboff\u00a0\u00bb da_exit_intent=\u00a0\u00bboff\u00a0\u00bb da_has_close=\u00a0\u00bbon\u00a0\u00bb da_alt_close=\u00a0\u00bboff\u00a0\u00bb da_dark_close=\u00a0\u00bboff\u00a0\u00bb da_not_modal=\u00a0\u00bbon\u00a0\u00bb da_is_singular=\u00a0\u00bboff\u00a0\u00bb da_with_loader=\u00a0\u00bboff\u00a0\u00bb da_has_shadow=\u00a0\u00bbon\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb15px||15px||true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p><span>La vaccination contre le zona dans le lupus est un domaine de recherche important, en particulier pour les personnes vivant avec un lupus \u00e9ryth\u00e9mateux syst\u00e9mique qui pr\u00e9sentent un risque accru d\u2019infection et de complications. Les programmes de financement de la recherche, tels que la <a href=\"https:\/\/www.lupuscanada.org\/fr\/programmes-de-financement-de-la-recherche\/\"><strong>subvention Catalyst Lupus Canada<\/strong><\/a>, jouent un r\u00f4le crucial dans l\u2019avancement de la compr\u00e9hension et du traitement du lupus au Canada. La subvention Catalyst facilite des recherches novatrices, permettant aux scientifiques et professionnels de sant\u00e9 d\u2019explorer de nouveaux concepts, d\u2019am\u00e9liorer les techniques diagnostiques, de d\u00e9velopper des traitements plus efficaces et de combler les lacunes en recherche tant pour le lupus \u00e9ryth\u00e9mateux disco\u00efde que syst\u00e9mique (LES).<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb-20px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_heading title=\u00a0\u00bbQu\u2019est-ce que le programme de subventions Catalyst Lupus Canada ?\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb title_level=\u00a0\u00bbh2&Prime; title_text_align=\u00a0\u00bbleft\u00a0\u00bb title_font_size=\u00a0\u00bb22px\u00a0\u00bb custom_margin=\u00a0\u00bb|48px|||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||0px|false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb15px||15px||true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p data-start=\"1106\" data-end=\"1368\">La subvention Catalyseur Lupus Canada soutient les chercheurs canadiens en phase de d\u00e9marrage dans le lancement d\u2019id\u00e9es et de projets de recherche innovants. Il est con\u00e7u pour compl\u00e9ter, et non pour concurrencer, les sources de financement traditionnelles telles que les Instituts canadiens de recherche en sant\u00e9 (IRSC). <\/p>\n<p data-start=\"1370\" data-end=\"1581\">En investissant dans de nouvelles recherches prometteuses, la subvention Catalyst contribue \u00e0 faire progresser les connaissances, \u00e0 renforcer les futures demandes de financement et \u00e0 acc\u00e9l\u00e9rer les progr\u00e8s vers une am\u00e9lioration des soins et des r\u00e9sultats pour les personnes vivant avec le lupus.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb-20px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_heading title=\u00a0\u00bb\u00c9tude financ\u00e9e par Catalyst Grant sur la vaccination contre le zona chez le lupus\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb title_level=\u00a0\u00bbh2&Prime; title_text_align=\u00a0\u00bbleft\u00a0\u00bb title_font_size=\u00a0\u00bb22px\u00a0\u00bb custom_margin=\u00a0\u00bb|48px|||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||0px|false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb1_2,1_2&Prime; _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb-20px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb1_2&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb15px||15px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||2px||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p data-start=\"1657\" data-end=\"1852\">L\u2019une des \u00e9tudes r\u00e9centes soutenues par la subvention Catalyst Lupus Canada a examin\u00e9 les sch\u00e9mas de vaccination contre le zona, la s\u00e9curit\u00e9 et la r\u00e9ponse immunitaire chez les personnes vivant avec un lupus \u00e9ryth\u00e9mateux syst\u00e9mique.<\/p>\n<p data-start=\"1854\" data-end=\"2039\">L\u2019\u00e9tude, <a href=\"https:\/\/www.lupuscanada.org\/fr\/lupus-canada-et-la-lupus-foundation-of-america-octroient-une-subvention-de-recherche-visant-a-reduire-le-risque-de-zona-chez-les-personnes-atteintes-de-lupus\/\"><em data-start=\"1865\" data-end=\"1936\">Vaccination REcombinante contre l\u2019herp\u00e8s ZostER en LE (LES<\/em><\/a>), a \u00e9t\u00e9 men\u00e9e par le Dr Arielle Mendel \u00e0 <a href=\"https:\/\/www.mcgill.ca\/expmed\/dr-arielle-mendel\" target=\"_blank\" rel=\"noopener\">l\u2019Institut de recherche du Centre de sant\u00e9 de l\u2019Universit\u00e9 McGill<\/a>.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_2&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_image src=\u00a0\u00bbhttps:\/\/www.lupuscanada.org\/wp-content\/uploads\/2025\/03\/Picture1.png\u00a0\u00bb alt=\u00a0\u00bbPhoto de profil du Dr Arielle Mendel, chercheuse sur le lupus \u00e9tudiant la vaccination contre le zona chez le lupus\u00a0\u00bb title_text=\u00a0\u00bbDr Arielle Mendel \u2013 Recherche sur la vaccination contre le zona et le lupus\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb width=\u00a0\u00bb65%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb0px||0px||true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_heading title=\u00a0\u00bbAper\u00e7u de l\u2019\u00e9tude et objectifs de recherche\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb title_level=\u00a0\u00bbh3&Prime; title_font=\u00a0\u00bb|300|||||||\u00a0\u00bb title_text_align=\u00a0\u00bbleft\u00a0\u00bb title_font_size=\u00a0\u00bb22px\u00a0\u00bb custom_margin=\u00a0\u00bb10px|48px|10px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||0px|true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb15px||15px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||2px||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p data-start=\"2089\" data-end=\"2371\">Les personnes atteintes de lupus sont particuli\u00e8rement \u00e0 risque de zona (zona), une r\u00e9activation du virus de la varicelle. <a href=\"https:\/\/www.lupuscanada.org\/fr\/vaccin-contre-le-zona-et-lupus-lupus-canada\/\">Le zona peut \u00eatre \u00e9vit\u00e9 par la vaccination<\/a> ; Cependant, des questions subsistent concernant l\u2019adoption du vaccin, la r\u00e9ponse immunitaire et le risque potentiel de pouss\u00e9es de lupus apr\u00e8s la vaccination.<\/p>\n<p data-start=\"2373\" data-end=\"2405\">Les objectifs de cette \u00e9tude \u00e9taient de :<\/p>\n<ul data-start=\"2406\" data-end=\"2625\">\n<li data-start=\"2406\" data-end=\"2471\">\n<p data-start=\"2408\" data-end=\"2471\">Comprendre les sch\u00e9mas de vaccination contre le zona chez les adultes atteints de lupus<\/p>\n<\/li>\n<li data-start=\"2472\" data-end=\"2543\">\n<p data-start=\"2474\" data-end=\"2543\">\u00c9valuer si la vaccination contre le zona est associ\u00e9e \u00e0 des pouss\u00e9es du lupus<\/p>\n<\/li>\n<li data-start=\"2544\" data-end=\"2625\">\n<p data-start=\"2546\" data-end=\"2625\">\u00c9valuer les r\u00e9ponses immunitaires au vaccin contre le zona chez les personnes vivant avec le lupus<\/p>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb0px||0px||true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_heading title=\u00a0\u00bbPrincipaux r\u00e9sultats de recherche\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb title_level=\u00a0\u00bbh2&Prime; title_text_align=\u00a0\u00bbleft\u00a0\u00bb title_font_size=\u00a0\u00bb22px\u00a0\u00bb custom_margin=\u00a0\u00bb10px|48px|10px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||0px|true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb0px||0px||true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_heading title=\u00a0\u00bbSch\u00e9mas de vaccination contre le zona chez les adultes atteints de lupus\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb title_level=\u00a0\u00bbh3&Prime; title_font=\u00a0\u00bb|300|||||||\u00a0\u00bb title_text_align=\u00a0\u00bbleft\u00a0\u00bb title_font_size=\u00a0\u00bb22px\u00a0\u00bb custom_margin=\u00a0\u00bb10px|48px|10px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||0px|true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb15px||15px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||2px||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p><span>Dans une analyse portant sur 647 adultes atteints de lupus, plus d\u2019un quart (27 %) avaient re\u00e7u au moins un vaccin contre le zona avant 2023. Suite \u00e0 une modification de la politique de sant\u00e9 publique en 2023 qui a offert la vaccination gratuite contre le zona aux adultes immunod\u00e9prim\u00e9s, les taux de vaccination contre le zona chez les personnes atteintes de lupus ont quadrupl\u00e9. <\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb0px||0px||true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_heading title=\u00a0\u00bbTaux de pouss\u00e9e du lupus apr\u00e8s la vaccination contre le zona\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb title_level=\u00a0\u00bbh3&Prime; title_font=\u00a0\u00bb|300|||||||\u00a0\u00bb title_text_align=\u00a0\u00bbleft\u00a0\u00bb title_font_size=\u00a0\u00bb22px\u00a0\u00bb custom_margin=\u00a0\u00bb10px|48px|10px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||0px|true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb15px||15px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||2px||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p><span>Les analyses pr\u00e9liminaires ont montr\u00e9 que les taux de pouss\u00e9e du lupus n\u2019\u00e9taient pas significativement plus \u00e9lev\u00e9s durant la p\u00e9riode de trois mois suivant la vaccination contre le zona, compar\u00e9s aux autres p\u00e9riodes de suivi. Ces r\u00e9sultats sugg\u00e8rent que la vaccination contre le zona n\u2019a pas \u00e9t\u00e9 associ\u00e9e \u00e0 une augmentation significative de l\u2019activit\u00e9 de la maladie dans cette cohorte. <\/span><\/p>\n<p>[\/et_pb_text][et_pb_heading title=\u00a0\u00bbR\u00e9ponse immunitaire \u00e0 la vaccination contre le zona chez le lupus\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb title_level=\u00a0\u00bbh3&Prime; title_font=\u00a0\u00bb|300|||||||\u00a0\u00bb title_text_align=\u00a0\u00bbleft\u00a0\u00bb title_font_size=\u00a0\u00bb22px\u00a0\u00bb custom_margin=\u00a0\u00bb10px|48px|10px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||0px|true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb15px||15px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||2px||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p data-start=\"3437\" data-end=\"3573\">Les r\u00e9ponses immunitaires au vaccin contre le zona ont \u00e9t\u00e9 \u00e9valu\u00e9es chez 46 participants ayant re\u00e7u des pr\u00e9l\u00e8vements sanguins avant et apr\u00e8s la vaccination.<\/p>\n<p data-start=\"3575\" data-end=\"3901\">Presque tous les participants (98 %) ont manifest\u00e9 une r\u00e9ponse immunitaire au vaccin, et environ les deux tiers (65 %) ont constat\u00e9 une augmentation quadruple des niveaux d\u2019anticorps par rapport au d\u00e9part. Les r\u00e9ponses immunitaires \u00e9taient similaires chez les participants prenant des immunosuppresseurs et ceux prenant uniquement ou sans antipaludiques contre le lupus. <\/p>\n<p data-start=\"3903\" data-end=\"4006\">Les analyses pr\u00e9liminaires n\u2019ont pas identifi\u00e9 de diff\u00e9rences dans la r\u00e9ponse immunitaire en fonction des intervalles de dosage des vaccins.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb0px||0px||true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_heading title=\u00a0\u00bbDurabilit\u00e9 de la protection par vaccin et consid\u00e9rations sur le rappel\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb title_level=\u00a0\u00bbh3&Prime; title_font=\u00a0\u00bb|300|||||||\u00a0\u00bb title_text_align=\u00a0\u00bbleft\u00a0\u00bb title_font_size=\u00a0\u00bb22px\u00a0\u00bb custom_margin=\u00a0\u00bb10px|48px|10px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||0px|true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb15px||15px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||2px||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p data-start=\"4103\" data-end=\"4406\">Parmi les participants ayant re\u00e7u des \u00e9chantillons sanguins r\u00e9p\u00e9t\u00e9s au fil du temps, les niveaux d\u2019anticorps contre le virus du zona ont consid\u00e9rablement diminu\u00e9 au fil du temps suivant la vaccination. Les \u00e9chantillons pr\u00e9lev\u00e9s plus de trois ans apr\u00e8s la derni\u00e8re dose du vaccin montraient des niveaux d\u2019anticorps ayant diminu\u00e9 \u00e0 des niveaux pr\u00e9-vaccinal. <\/p>\n<p data-start=\"4408\" data-end=\"4594\">Ces r\u00e9sultats sugg\u00e8rent la possibilit\u00e9 que la protection contre le zona diminue avec le temps chez les personnes atteintes de lupus, ce qui sugg\u00e8re que des vaccinations de rappel contre le zona pourraient \u00eatre n\u00e9cessaires \u00e0 l\u2019avenir.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb0px||0px||true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_heading title=\u00a0\u00bbPr\u00e9sentation de la recherche et prochaines \u00e9tapes\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb title_level=\u00a0\u00bbh2&Prime; title_text_align=\u00a0\u00bbleft\u00a0\u00bb title_font_size=\u00a0\u00bb22px\u00a0\u00bb custom_margin=\u00a0\u00bb10px|48px|10px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||0px|true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb15px||15px||true|false\u00a0\u00bb custom_padding=\u00a0\u00bb|0px||2px||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p data-start=\"4667\" data-end=\"4828\">Cette recherche a \u00e9t\u00e9 pr\u00e9sent\u00e9e lors d\u2019un congr\u00e8s international de rhumatologie en octobre 2025 et est actuellement en pr\u00e9paration pour publication dans une revue \u00e0 comit\u00e9 de lecture.<\/p>\n<p data-start=\"4830\" data-end=\"4964\">Des recherches suppl\u00e9mentaires aideront \u00e0 clarifier la protection vaccinale \u00e0 long terme et \u00e0 orienter les strat\u00e9gies futures de vaccination pour les personnes vivant avec le lupus.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_image=\u00a0\u00bbhttps:\/\/www.lupuscanada.org\/wp-content\/uploads\/2024\/05\/Rectangle-1674.png\u00a0\u00bb custom_margin=\u00a0\u00bb20px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_heading title=\u00a0\u00bbEn savoir plus sur le financement de la recherche sur le lupus\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb title_level=\u00a0\u00bbh2&Prime; title_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb custom_margin=\u00a0\u00bb30px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb link_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb custom_margin=\u00a0\u00bb-16px||30px||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb6px||0px|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p><span style=\"color: #ffffff;\">Pour en savoir plus sur le <a href=\"https:\/\/www.lupuscanada.org\/fr\/programmes-de-financement-de-la-recherche\/\">programme de subventions Catalyst<\/a> de Lupus Canada et explorer les initiatives de recherche pass\u00e9es et actuelles, visitez notre page Programmes de financement de la recherche.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_button button_url=\u00a0\u00bbhttps:\/\/www.lupuscanada.org\/fr\/recherche-canadienne-sur-le-lupus\/\u00a0\u00bb url_new_window=\u00a0\u00bbon\u00a0\u00bb button_text=\u00a0\u00bbExplorez les programmes de financement de la recherche sur le lupus\u00a0\u00bb button_alignment=\u00a0\u00bbcenter\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.5&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb button_text_size=\u00a0\u00bb18px\u00a0\u00bb button_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb button_bg_color=\u00a0\u00bb#6B198A\u00a0\u00bb custom_margin=\u00a0\u00bb38px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La vaccination contre le zona chez le lupus est examin\u00e9e dans cette \u00e9tude de la subvention Catalyst Lupus Canada, qui explore la s\u00e9curit\u00e9 du vaccin, la r\u00e9ponse immunitaire et le risque de pouss\u00e9e du lupus.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[92],"tags":[],"topic":[115,130],"audience":[123,122,125,124],"class_list":["post-11834","post","type-post","status-publish","format-standard","hentry","category-article-fr","topic-recherche-et-essais-cliniques","topic-subvention-catalyseur","audience-j-ai-le-lupus","audience-j-ai-recemment-recu-un-diagnostic","audience-professionnel-de-la-sante","audience-une-personne-a-qui-je-tiens-a-le-lupus"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/posts\/11834","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/comments?post=11834"}],"version-history":[{"count":0,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/posts\/11834\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/media?parent=11834"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/categories?post=11834"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/tags?post=11834"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/topic?post=11834"},{"taxonomy":"audience","embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/audience?post=11834"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}